Summary:
- Neuralink, a company founded by Elon Musk, has filed for approval with the U.S. Food and Drug Administration (FDA) to begin human trials of its brain-computer interface technology.
- Neuralink's technology aims to create a wireless device that can be implanted in the human brain, allowing for direct communication between the brain and a computer.
- This technology could potentially help people with neurological conditions or disabilities by providing a way for the brain to control external devices or restore lost functions.